Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Clinical Colorectal Cancer|December 17, 2016
Perioperative Triplet Chemotherapy and Cetuximab in Patients With RAS Wild Type High Recurrence Risk or Borderline Resectable Colorectal Cancer Liver MetastasesFilippo Pietrantonio, Maria Di Bartolomeo, Christian Cotsoglou, et al.
Lancet (London, England)|May 5, 2009
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trialRobert Pirker, Jose R Pereira, Aleksandra Szczesna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2011
Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 (Toll-like receptor 9 agonist) as first-line treatment for advanced non-small-cell lung cancerVera Hirsh, Luis Paz-Ares, Michael Boyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology GroupRichard Herrmann, György Bodoky, Thomas Ruhstaller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2008
Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001Jürg Bernhard, Daniel Dietrich, Werner Scheithauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Phase II study of asparagine-glycine-arginine-human tumor necrosis factor alpha, a selective vascular targeting agent, in previously treated patients with malignant pleural mesotheliomaVanesa Gregorc, Paolo A Zucali, Armando Santoro, et al.
Anticancer Research|July 18, 2008
Palliative treatment for elderly patients with colon cancer in ten Italian medical oncology unitsLara Maria Pasetto, Cristina Falci, Elisa Rizzo, et al.
Anticancer Research|August 30, 2008
Adjuvant treatment for elderly patients with colon cancer. An observational studyLara Maria Pasetto, Cristina Falci, Umberto Basso, et al.
The Lancet. Oncology|November 22, 2012
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trialAimery de Gramont, Eric Van Cutsem, Hans-Joachim Schmoll, et al.
Pageof 10